Search Results - "van Tienoven, Doorlène"

The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children by Siegers, Kris E, van Herwaarden, Antonius E, de Waard, Jacobus H, del Nogal, Berenice, Hermans, Peter W. M, van Tienoven, Doorlène, Berbers, Guy A. M, de Jonge, Marien I, Verhagen, Lilly M

“…Background Almost 200 million children worldwide are either undernourished or overweight. Only a few studies have addressed the effect of variation in…”
Get full text

Serum FGF21 levels in adult m.3243A>G carriers: Clinical implications by Koene, Saskia, de Laat, Paul, van Tienoven, Doorlène H, Vriens, Dennis, Brandt, André M, Sweep, Fred C.G.J, Rodenburg, Richard J.T, Donders, A. Rogier T, Janssen, Mirian C.H, Smeitink, Jan A.M

“…OBJECTIVES:To determine the value of fibroblast growth factor 21 (FGF21), a recently discovered biomarker for mitochondrial disease, in predicting clinical…”
Get full text

Complex of urokinase‐type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node–negative breast carcinoma by Manders, Peggy, Tjan‐Heijnen, Vivianne C. G., Span, Paul N., Grebenchtchikov, Nicolai, Geurts‐Moespot, Anneke, van Tienoven, Doorlène T. H., Beex, Louk V. A. M., Sweep, Fred C. G. J.

“…BACKGROUND The ability of a solid tumor to grow and metastasize has a significant dependence on protease systems, such as the plasminogen activation system…”
Get full text

Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers by Koene, Saskia, de Laat, Paul, van Tienoven, Doorlène H., Weijers, Gert, Vriens, Dennis, Sweep, Fred C. G. J., Timmermans, Janneke, Kapusta, Livia, Janssen, Mirian C. H., Smeitink, Jan A. M.

“…In this observational cohort study, we examined the prognostic value of growth and differentiation factor 15 (GDF15) in indicating and monitoring general…”
Get full text

Longitudinal trends in thyroid function in relation to iodine intake: ongoing changes of thyroid function despite adequate current iodine status by van de Ven, Annenienke C, Netea-Maier, Romana T, Ross, H Alec, van Herwaarden, Teun A E, Holewijn, Suzanne, de Graaf, Jacqueline, Kiemeney, Bart L A, van Tienoven, Doorlène, Wetzels, Jack F M, Smit, Johannes W, Sweep, Fred C G J, Hermus, Ad R M M, den Heijer, Martin

“…ObjectiveSeveral cross-sectional studies on populations with iodine deficiency showed that TSH-levels are negatively associated with age, while in populations…”
Get full text

The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer by Dorssers, Lambert C J, Grebenchtchikov, Nicolai, Brinkman, Arend, Look, Maxime P, van Broekhoven, Simone P J, de Jong, Danielle, Peters, Harry A, Portengen, Henk, Meijer-van Gelder, Marion E, Klijn, Jan G M, van Tienoven, Doorlene T H, Geurts-Moespot, Anneke, Span, Paul N, Foekens, John A, Sweep, Fred C G J

“…Purpose: BCAR1, the human homologue of the rat p130Cas protein, was identified in a functional screen for human breast cancer cell proliferation resistant to…”
Get full text

Vascular Endothelial Growth Factor Independently Predicts the Efficacy of Postoperative Radiotherapy in Node-Negative Breast Cancer Patients by MANDERS, Peggy, SWEEP, Fred C. G. J, TJAN-HEIJNEN, Vivianne C. G, GEURTS-MOESPOT, Anneke, VAN TIENOVEN, Doorléne T. H, FOEKENS, John A, SPAN, Paul N, BUSSINK, Jan, BEEX, Louk V. A. M

“…Purpose: Vascular endothelial growth factor (VEGF) is a mediator of angiogenesis and is up-regulated under hypoxic conditions. Hypoxic tumors are known to…”
Get full text

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer by Manders, Peggy, Tjan-Heijnen, Vivianne C G, Span, Paul N, Grebenchtchikov, Nicolai, Geurts-Moespot, Anneke J, van Tienoven, Doorléne T H, Beex, Louk V A M, Sweep, Fred C G J

“…It has been shown that urokinase-type plasminogen activator (uPA) and its main inhibitor (PAI-I) have predictive value for therapy success in advanced breast…”
Get more information

High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer by SPAN, Paul N, TJAN-HEIJNEN, Vivianne C. G, MANDERS, Peggy, VAN TIENOVEN, Doorlene, LEHR, Jeffrey, SWEEP, Fred C. G. J

“…Variants of survivin with differing subcellular localizations might mediate the different functions of survivin, i.e. cell-cycle regulation and apoptosis…”
Get full text

Human Anti-mouse IgM and IgG Responses in Ovarian Cancer Patients after Radioimmunotherapy with 90Y-muHMFG1 by OEI, Angèle L. M, SWEEP, Fred C. G. J, GEURTS-MOESPOT, Anneke, VAN TIENOVEN, Doorlène, VON MENSDORFF-POUILLY, Silvia, THOMAS, Chris M. G, MASSUGER, Leon F. A. G

“…Background: Human anti-mouse antibody (HAMA)-IgM and IgG in ovarian cancer patients treated with intraperitoneal (i.p.) 90 Y-muHMFG1 as consolidating therapy…”
Get full text

Serum Fibroblast Growth Factor 21 (FGF-21) levels: Is there a correlation with disease severity and disease progression in m.3243A>G carriers? by Koene, Saskia, de Laat, Paul, Vriens, Dennis, van Tienoven, Doorlene H., Brandt, André M., Sweep, Fred C.G.J., Borm, George, Janssen, Mirian C.H., Smeitink, Jan A.M.

Get full text